Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Subcutaneous immunotherapy (SCIT) is a unique therapy for allergic disease because it provides symptomatic relief while modifying the allergic disease by targeting the underlying immunological mechanism.
The report details the trend, potential and market size of Subcutaneous Immunotherapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Subcutaneous Immunotherapymarket, defines the market attractiveness level of Subcutaneous Immunotherapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Subcutaneous Immunotherapy industry, describes the types of Subcutaneous Immunotherapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Subcutaneous Immunotherapy market and the development prospects and opportunities of Subcutaneous Immunotherapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Subcutaneous Immunotherapy market in Chapter 13.
By Player:
Anergis
Biomay AG
Stallergenes Greer
ALK
Merck KGaA
DBV Technologies
Aimmune Therapeutics
Allergy Therapeutics
HAL Allergy BV
Circassia
By Type:
Asthma
Allergic Rhinitis
Venom Allergy
Food Allergy
By End-User:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Subcutaneous Immunotherapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Subcutaneous Immunotherapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Subcutaneous Immunotherapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Subcutaneous Immunotherapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Subcutaneous Immunotherapy Market Analysis and Outlook to 2022
-
7.1 Global Subcutaneous Immunotherapy Consumption (2017-2022)
-
7.2 United States Subcutaneous Immunotherapy Consumption (2017-2022)
-
7.3 Europe Subcutaneous Immunotherapy Consumption (2017-2022)
-
7.4 China Subcutaneous Immunotherapy Consumption (2017-2022)
-
7.5 Japan Subcutaneous Immunotherapy Consumption (2017-2022)
-
7.6 India Subcutaneous Immunotherapy Consumption (2017-2022)
-
7.7 South Korea Subcutaneous Immunotherapy Consumption (2017-2022)
8 Region and Country-wise Subcutaneous Immunotherapy Market Analysis and Outlook to 2028
-
8.1 Global Subcutaneous Immunotherapy Consumption Forecast (2022-2028)
-
8.2 United States Subcutaneous Immunotherapy Consumption Forecast (2022-2028)
-
8.3 Europe Subcutaneous Immunotherapy Consumption Forecast (2022-2028)
-
8.4 China Subcutaneous Immunotherapy Consumption Forecast (2022-2028)
-
8.5 Japan Subcutaneous Immunotherapy Consumption Forecast (2022-2028)
-
8.6 India Subcutaneous Immunotherapy Consumption Forecast (2022-2028)
-
8.7 South Korea Subcutaneous Immunotherapy Consumption Forecast (2022-2028)
9 Global Subcutaneous Immunotherapy Market Outlook by Types and Applications to 2022
-
9.1 Global Subcutaneous Immunotherapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Asthma Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Allergic Rhinitis Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Venom Allergy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Food Allergy Consumption and Growth Rate (2017-2022)
-
9.2 Global Subcutaneous Immunotherapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Subcutaneous Immunotherapy Market Outlook by Types and Applications to 2028
-
10.1 Global Subcutaneous Immunotherapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Asthma Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Allergic Rhinitis Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Venom Allergy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Food Allergy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Subcutaneous Immunotherapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Subcutaneous Immunotherapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Subcutaneous Immunotherapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Subcutaneous Immunotherapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Subcutaneous Immunotherapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Subcutaneous Immunotherapy Market Competitive Analysis
-
14.1 Anergis
-
14.1.1 Anergis Company Details
-
14.1.2 Anergis Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Anergis Subcutaneous Immunotherapy Product and Service
-
14.2 Biomay AG
-
14.2.1 Biomay AG Company Details
-
14.2.2 Biomay AG Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Biomay AG Subcutaneous Immunotherapy Product and Service
-
14.3 Stallergenes Greer
-
14.3.1 Stallergenes Greer Company Details
-
14.3.2 Stallergenes Greer Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Stallergenes Greer Subcutaneous Immunotherapy Product and Service
-
14.4 ALK
-
14.4.1 ALK Company Details
-
14.4.2 ALK Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 ALK Subcutaneous Immunotherapy Product and Service
-
14.5 Merck KGaA
-
14.5.1 Merck KGaA Company Details
-
14.5.2 Merck KGaA Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Merck KGaA Subcutaneous Immunotherapy Product and Service
-
14.6 DBV Technologies
-
14.6.1 DBV Technologies Company Details
-
14.6.2 DBV Technologies Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 DBV Technologies Subcutaneous Immunotherapy Product and Service
-
14.7 Aimmune Therapeutics
-
14.7.1 Aimmune Therapeutics Company Details
-
14.7.2 Aimmune Therapeutics Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Aimmune Therapeutics Subcutaneous Immunotherapy Product and Service
-
14.8 Allergy Therapeutics
-
14.8.1 Allergy Therapeutics Company Details
-
14.8.2 Allergy Therapeutics Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Allergy Therapeutics Subcutaneous Immunotherapy Product and Service
-
14.9 HAL Allergy BV
-
14.9.1 HAL Allergy BV Company Details
-
14.9.2 HAL Allergy BV Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 HAL Allergy BV Subcutaneous Immunotherapy Product and Service
-
14.10 Circassia
-
14.10.1 Circassia Company Details
-
14.10.2 Circassia Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Circassia Subcutaneous Immunotherapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Subcutaneous Immunotherapy
-
Figure Subcutaneous Immunotherapy Picture
-
Table Global Subcutaneous Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Subcutaneous Immunotherapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Subcutaneous Immunotherapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Subcutaneous Immunotherapy Consumption by Country (2017-2022)
-
Figure United States Subcutaneous Immunotherapy Consumption and Growth Rate (2017-2022)
-
Table Europe Subcutaneous Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure China Subcutaneous Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Subcutaneous Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure India Subcutaneous Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Subcutaneous Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Subcutaneous Immunotherapy Consumption Forecast by Country (2022-2028)
-
Figure United States Subcutaneous Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Subcutaneous Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Subcutaneous Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Subcutaneous Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Subcutaneous Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Subcutaneous Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Asthma Consumption and Growth Rate (2017-2022)
-
Figure Global Allergic Rhinitis Consumption and Growth Rate (2017-2022)
-
Figure Global Venom Allergy Consumption and Growth Rate (2017-2022)
-
Figure Global Food Allergy Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Asthma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Allergic Rhinitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Venom Allergy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Food Allergy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Subcutaneous Immunotherapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Subcutaneous Immunotherapy Export by Region (Top 5 Countries) (2017-2028)
-
Table Anergis (Foundation Year, Company Profile and etc.)
-
Table Anergis Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Anergis Subcutaneous Immunotherapy Product and Service
-
Table Biomay AG (Foundation Year, Company Profile and etc.)
-
Table Biomay AG Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biomay AG Subcutaneous Immunotherapy Product and Service
-
Table Stallergenes Greer (Foundation Year, Company Profile and etc.)
-
Table Stallergenes Greer Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Stallergenes Greer Subcutaneous Immunotherapy Product and Service
-
Table ALK (Foundation Year, Company Profile and etc.)
-
Table ALK Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table ALK Subcutaneous Immunotherapy Product and Service
-
Table Merck KGaA (Foundation Year, Company Profile and etc.)
-
Table Merck KGaA Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck KGaA Subcutaneous Immunotherapy Product and Service
-
Table DBV Technologies (Foundation Year, Company Profile and etc.)
-
Table DBV Technologies Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table DBV Technologies Subcutaneous Immunotherapy Product and Service
-
Table Aimmune Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Aimmune Therapeutics Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aimmune Therapeutics Subcutaneous Immunotherapy Product and Service
-
Table Allergy Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Allergy Therapeutics Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergy Therapeutics Subcutaneous Immunotherapy Product and Service
-
Table HAL Allergy BV (Foundation Year, Company Profile and etc.)
-
Table HAL Allergy BV Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table HAL Allergy BV Subcutaneous Immunotherapy Product and Service
-
Table Circassia (Foundation Year, Company Profile and etc.)
-
Table Circassia Subcutaneous Immunotherapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Circassia Subcutaneous Immunotherapy Product and Service
-
